Skip to content

SelectQuote SLQT Proceeds From Issuance Of Convertible Preferred Stock

Proceeds From Issuance Of Convertible Preferred Stock at other companies

SelectQuote logo
SelectQuoteSLQT
$84.46M
New Horizon Aircraft logo
New Horizon AircraftHOVR
$13K
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$26.55M
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$5.69M
HTF
Heartflow, Inc. Common StockHTFL
$42.24M
KKR & Co. logo
KKR & Co.KKR
$0-100%

Other financials

Income statement

See full
Revenue$430.9M+5.6%
Gross profit$259.6M+5.6%
Operating income$35.9M+62.9%
Net income$40.2M+54.5%
EPS (diluted)$0.11+267%

Balance sheet

See full
Cash & equivalents$35.2M-59.2%
Total debt$404.8M-4.5%
Total equity$384.7M+9.9%
Total assets$1.3B+3.0%

Cash flow

See full
Operating cash flow$56.8M-20.2%
CapEx$947.0K-0.2%
Free cash flow$55.8M-20.4%

Valuation

See full
Market cap$139.42M-65.1%
Enterprise value$509.04M-34.8%
P/E1.5×-6.9×
P/S0.1×-0.2×

Profitability

See full
Gross margin54.2%-7.6pp
Operating margin5.4%
Net margin5.6%+5.3pp
FCF margin-0.4%-3.3pp

Returns & leverage

See full
Return on equity25%+23.9pp
Debt / equity1.1×-0.2×
Current ratio1.6×-0.3×

Where this comes from

Reported directly by SelectQuote in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock.

The official record: SelectQuote’s 10-K, filed August 21, 2025, on SEC EDGAR. View the filing →

Ask your AI about SelectQuote's proceeds from issuance of convertible preferred stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SelectQuote's proceeds from issuance of convertible preferred stock?
SelectQuote (SLQT) reported proceeds from issuance of convertible preferred stock of $84.46M in Q2 2025.
What does proceeds from issuance of convertible preferred stock mean?
Represents the total cash proceeds raised from the issuance of preferred equity that carries conversion rights into common stock. This highlights the company's strategy for raising capital while balancing equity dilution and dividend obligations.